← Back to Patent Explorer
US4046889A Expired / Lapsed US ⏱️ 0.0 years remaining

Azetidine-2-carboxylic acid derivatives

Assignee: ER Squibb and Sons LLC
•
Filing: 1976-02-13
•
Granted: 1977-09-06
•
Expires: 1996-02-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract New proline derivatives and related compounds which have the general formula ##STR1## are useful as angiotensin converting enzyme inhibitors.

Inventors

  • 👤 Miguel Angel Ondetti
  • 👤 David W. Cushman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 05:21
CPC Classifications
C; C07; C07D; C07D211/00; C07D211/04; C07D211/06; C07D211/36; C07D211/60; A; A61; A61P; A61P43/00; A61P9/00; A61P9/12; C07C; C07C321/00; C07C323/00; C07C327/00; C07C53/00; C07C53/15; C07C53/19; C07C57/00; C07C57/52; C07C57/58; C07D205/00; C07D205/02; C07D205/04; C07D207/00; C07D207/02; C07D207/04; C07D207/10; C07D207/16

Claims Analysis

Total Claims: 24
Claim 1
Independent Claim 65 words
A compound of the formula ##STR14## wherein R is hydroxy, amino or lower alkoxy; R 1 and R 4 each is hydrogen, lower alkyl or phenyl-lower alkyl; R 2 is hydrogen or R 5 --CO; R 3 is hydrogen, hydroxy or lower alkyl; R 5 is lower alkyl, phenyl or phenyl-lower alkyl; m is 1; n is 0, 1 or 2. and basic salts thereof.
Claim 2
Dependent Claim 65 words
A compound of the formula ##STR14## wherein R is hydroxy, amino or lower alkoxy; R 1 and R 4 each is hydrogen, lower alkyl or phenyl-lower alkyl; R 2 is hydrogen or R 5 --CO; R 3 is hydrogen, hydroxy or lower alkyl; R 5 is lower alkyl, phenyl or phenyl-lower alkyl; m is 1; n is 0, 1 or 2. and basic salts thereof.
Claim 3
Dependent Claim 53 words
A compound as in claim 1 wherein R is hydroxy or lower alkoxy; R 1 is hydrogen or lower alkyl; R 2 is hydrogen or R 5 --CO; R 3 and R 4 each is hydrogen; R 5 is lower alkyl or phenyl; m is 1 and n is 0, 1 or 2.
Claim 4
Dependent Claim 15 words
A compound as in claim 1 wherein R 3 and R 4 each is hydrogen.
Claim 5
Dependent Claim 15 words
A compound as in claim 1 wherein m is 1 and R 3 is hydrogen.
Claim 6
Dependent Claim 8 words
The L-form of a compound of claim 1.
Claim 7
Dependent Claim 10 words
A compound as in claim 1 wherein R is hydroxy.
Claim 8
Dependent Claim 10 words
A compound as in claim 1 wherein n is 1.
Claim 9
Dependent Claim 14 words
A compound as in claim 1 wherein R 2 is hydrogen or lower alkanoyl.
Claim 10
Dependent Claim 11 words
A compound as in claim 1 wherein R 2 is hydrogen.
Claim 11
Dependent Claim 11 words
A compound as in claim 1 wherein R 2 is acetyl.
Claim 12
Dependent Claim 14 words
A compound as in claim 1 wherein R 1 is hydrogen or lower alkyl.
Claim 13
Dependent Claim 13 words
A compound as in claim 1 wherein R 1 is hydrogen or methyl.
Claim 14
Dependent Claim 17 words
A compound as in claim 1 wherein R is hydroxy and R 1 is hydrogen or methyl.
Claim 15
Dependent Claim 32 words
A composition comprising a compound of claim 1 in an amount sufficient to reduce blood pressure by inhibiting the conversion of angiotension I to angiotension II and a pharmaceutically acceptable vehicle therefor.
Claim 16
Dependent Claim 51 words
A method for reducing blood pressure by inhibiting the conversion of angiotensin I to angiotensin II which comprises administering a composition comprising a compound of claim 1 in an amount sufficient to reduce blood pressure by inhibiting the conversion of angiotension I to angiotension II and a pharmaceutically acceptable vehicle therefor.
Claim 17
Dependent Claim 10 words
A compound as in claim 1 wherein n is 0.
Claim 18
Dependent Claim 23 words
A compound as in claim 16 wherein R is hydroxy, R 1 and R 3 each is hydrogen and R 2 is benzoyl.
Claim 19
Dependent Claim 22 words
A compound as in claim 16 wherein R is hydroxy and R 1 , R 2 and R 3 each is hydrogen.
Claim 20
Dependent Claim 25 words
A compound as in claim 7 wherein R is hydroxy and R 1 , R 2 , R 4 and R 3 each is hydrogen.
Claim 21
Dependent Claim 26 words
A compound as in claim 7 wherein R is hydroxy, R 1 is methyl and R 2 , R 4 and R 3 each is hydrogen.
Claim 22
Dependent Claim 12 words
The compound of claim 18 wherein the azetidine is in the L-form.
Claim 23
Dependent Claim 12 words
The compound of claim 19 wherein the azetidine is in the L-form.
Claim 24
Dependent Claim 12 words
The compound of claim 20 wherein the azetidine is in the L-form.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-09-05 1981-03-07 1981-09-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-09-05 1985-03-07 1985-09-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-09-05 1989-03-07 1989-09-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag